{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:00:30Z","timestamp":1758052830852,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007582","name":"Alberta Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.clinbiochem.2021.09.013","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T03:01:41Z","timestamp":1633575701000},"page":"17-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Updated reference intervals for urine normetanephrine have no effect on test sensitivity but fewer false positives"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9360","authenticated-orcid":false,"given":"Gregory A.","family":"Kline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hyrcza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Pacaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice L.","family":"Pasieka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein S.M.","family":"Sadrzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2021.09.013_b0005","doi-asserted-by":"crossref","unstructured":"Eisenhofer G, Peitzsch M. Laboratory evaluation of pheochromocytoma and paraganglioma. Clinical Chemistry. 2014. p. 1486\u201399.","DOI":"10.1373\/clinchem.2014.224832"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.09.013_b0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","article-title":"Clinical Spectrum of Pheochromocytoma","volume":"209","author":"Guerrero","year":"2009","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.clinbiochem.2021.09.013_b0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2020.01.005","article-title":"Very high rate of false positive biochemical results when screening for pheochromocytoma in a large, undifferentiated population with variable indications for testing","volume":"77","author":"Kline","year":"2020","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.09.013_b0020","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2021.09.013_b0025","doi-asserted-by":"crossref","unstructured":"Timmers HJLM, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro- deoxyglucose, and18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009;94(12):4757\u201367.","DOI":"10.1210\/jc.2009-1248"},{"issue":"7417","key":"10.1016\/j.clinbiochem.2021.09.013_b0030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/bmj.327.7417.716","article-title":"Understanding sensitivity and specificity with the right side of the brain","volume":"327","author":"Loong","year":"2003","journal-title":"Bmj."},{"key":"10.1016\/j.clinbiochem.2021.09.013_b0035","doi-asserted-by":"crossref","unstructured":"Leung AA, Pasieka JL, Hyrcza MD, Pacaud D, Dong Y, Boyd J, et al. Epidemiology of pheochromocyoma and paraganglioma: population-based cohort study. Eur J Endocrinol. 2020;(Oct 1;1):(aop).","DOI":"10.1530\/EJE-20-0628"},{"key":"10.1016\/j.clinbiochem.2021.09.013_b0040","doi-asserted-by":"crossref","unstructured":"Ebbehoj A, Stochholm K, Jacobsen S, Trolle C, Jepsen P, Robaczyk M, et al. Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study. J Clin Endocrinol Metab. 2021;106(5):e2251-61.","DOI":"10.1210\/clinem\/dgaa965"},{"key":"10.1016\/j.clinbiochem.2021.09.013_b0045","doi-asserted-by":"crossref","unstructured":"Boyd J, Leung AA, Sadrzadeh H, Pamporaki C, Pacak K, Deutschbein T, et al. A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position. Eur. J. Endocrinol. 2019;181(3):301\u20139.","DOI":"10.1530\/EJE-19-0176"},{"key":"10.1016\/j.clinbiochem.2021.09.013_b0050","doi-asserted-by":"crossref","unstructured":"Eisenhofer G, Huynh TT, Hiroi M, Pacak K. Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of Pheochromocytoma. Rev Endocr Metab Disord [Internet]. 2001 [cited 2018 Sep 16];2(3):297\u2013311. Available from: http:\/\/link.springer.com\/10.1023\/A:1011572617314.","DOI":"10.1023\/A:1011572617314"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.09.013_b0055","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.09.013_b0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1503\/cmaj.1031666","article-title":"Tips for learners of evidence-based medicine: 5. The effect of spectrum of disease on the performance of diagnostic tests","volume":"173","author":"Montori","year":"2005","journal-title":"Cmaj."},{"key":"10.1016\/j.clinbiochem.2021.09.013_b0065","doi-asserted-by":"crossref","unstructured":"Eisenhoffer G, Deutschbein T, Constantinescu G, Langton K, Pamporaki C, Calsina B, et al. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. Clin Chem Lab Med. 2021;59(353\u201363).","DOI":"10.1515\/cclm-2020-0904"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021002708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021002708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:58:36Z","timestamp":1757865516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021002708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":13,"alternative-id":["S0009912021002708"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.09.013","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated reference intervals for urine normetanephrine have no effect on test sensitivity but fewer false positives","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}